1. Pets in Australia 2019. (2019). Sydney: Newgate Research and Animal Medicines Australia. Available at: http://animalmedicinesaustralia.org.au

2. Data on file, Virbac pet owner survey 2016.

3. Padula, A.M.. GnRH analogues – agonists and antagonists. Animal Reproduction Science 2005; 8 (1-2):115-126

4. England, G. Physiology and endocrinology of the female in: England and von Heimendahl eds. BSAVA Manual of canine and feline reproduction and neonatology, 2nd Ed, BSAVA; 2010, 1-12

5. Chastain C. B. and Ganjam V. K. The endocrine brain and clinical tests of its function in: Clinical endocrinology of companion animals. Philadelphia. 1986; 3, 37-68.

6. Beijerink NJ, Buijtels JJ, Okkens AC, Kooistra HS, Dieleman SJ (2007) Basal and GnRHinduced secretion of FSH and LH in anestrous versus ovariectomized bitches. Theriogenology. 67(5)L1039-45.

7. Greene JM, Ginther OJ (2015) Circulating nitric oxide metabolites during luteolysis and the effect of luteinizing hormone on circulating nitric oxide metabolites in heifers. Theriogenology. 83(2): 213-21.

8. Kutzler MA (2019) Non-neoplastic and neoplastic disorders linked to desexing in dogs. Proceedings of the AVA Annual Conference, Perth 2019. 356-368.

9. Joshua Jo (1965) The spaying of Bitches. Vet Rec. 77:642-6.

10. Arnold S (1997) Urinary incontinence in castrated bitches. Part 1: Significance, clinical aspects and etiopathogenesis. Schweiz Arch Tierheilkd. 139(6)271-6.

11. Stocklin-Gautschi NM, Ha¨ ssig M, Reichler IM, Hubler M, Arnold S (2001) The relationship of urinary incontinence to early spaying in bitches. J Reprod Fertil. 57(Suppl):233-236.

12. Angiolettti A, De Francesco I, Vergottini M, Battocchio ML (2004) Urinary incontinence after spaying in the bitch: incidence and oestrogen therapy. Veterinary Research Communication. 28 (Suppl 1):153-155.

13. Spain CV, Scarlett JM, Houpt KA (2004) Long-term risks and benefits of early-age gonadectomy in dogs. J Am Vet Med Assoc. 224:380-387.

14. Coit VA, Dowell FJ, Evans NP (2009) Neutering affects mRNA expression levels for the LH- and GnRH-receptors in the canine urinary bladder. Theriogenology. 71(2):239-247.

15. Angiolettti A, De Francesco I, Vergottini M, Battocchio ML (2004) Urinary incontinence after spaying in the bitch: incidence and oestrogen therapy. Veterinary Research Communication. 28 (Suppl 1):153-155.

16. Rosin AE, Barsanti JA (1981) Diagnosis of urinary incontinence in dogs: role of the urethral pressure profile. J Am Vet Med Assoc. 178:813-822.

17. Hill K, Jordan D, Ray J, Mays AA, Griffin K (2012) Medical therapy for acquired urinary incontinence in dogs. Int J Pharm Compd. 16(5):369-75.

18. Veronesi MC, Rota A, Battocchio M, Faustini M, Mollo A (2009) Spaying-related urinary incontinence and oestrogen therapy in the bitch. Acta Vet Hung. 57(1):171-82.

19. Mandigers RJ, Nell T (2001) Treatment of bitches with acquired urinary incontinence with oestriol. Vet Rec. 149(25):764-767.

20. Reichler IM, Hubler M, Jöchle W, Trigg TE, Piché CA, Arnold S (2003) The effect of GnRH analogs on urinary incontinence after ablation of the ovaries in dogs. Theriogenology. 60(7):1207-1216.

21. Reichler IM, Barth A, Piché CA, Jöchle W, Roos M, Hubler M, Arnold S (2006) Urodynamic parameters and plasma LH/FSH in spayed Beagle bitches before and 8 weeks after GnRH depot analogue treatment. Theriogenology. 66(9). P 2127-36.

22. Donovan CE, Weston A, MA Kutzler MA (2013) Gonadotropin-releasing hormone immunization to treat urethral sphincter mechanism incompetence in a bitch that experienced an adverse reaction to phenylpropanolamine. J Vet Sci Med Diagn. 2:3.

23. Donovan CE, Gordon JM, Kutzler MA (2014) Gonadotropin-releasing hormone immunization for the treatment of urethral sphincter mechanism incompetence in ovariectomized bitches. Theriogenology. 81(2):196-202.

24. Shoop SJ, Marlow S, Church DB, English K, McGreevy PD, Stell AJ, Thomson PC, O'Neill DG, Brodbelt DC (2015) Prevalence and risk factors for mast cell tumours in dogs in England. Canine Genet Epidemiol. 26(2):1 doi: 10.1186/2052-6687-2-1

25. Moccia V, Löhr C, Kutzler M. (2018) Immunohistochemical localization of LH receptors in canine cutaneous mast cell tumor. Proceedings for the Symposium for the Alliance for Contraception in Cats and Dogs. Boston, MA.

26. Torres de la Riva G, Hart BL, Farver TB, Oberbauer AM, Messam LL, Willits N, Hart LA. (2013) Neutering dogs: effects on joint disorders and cancers in golden retrievers. PLOS One. 8(2):P55937.

27. Zink MC, Farhoody P, Elser SE, Ruffini LD, Gibbons TA, Rieger RH (2014) Evaluation of the risk and age of onset of cancer and behavioral disorders in gonadectomized Vizslas. J Am Vet Med Assoc. 244(3):309-319.

28. White CR, Hohenhaus AE, Kelsey J, Procter-Gray E (2011) Cutaneous MCTs: associations with spay/neuter status, breed, body size, and phylogenetic cluster. J Am Anim Hosp Assoc. 47(3):210-216.

29. Kutzler MA (2019) Non-neoplastic and neoplastic disorders linked to desexing in dogs. Proceedings of the AVA Annual Conference, Perth 2019. 356-368.

30. Vail DM, MacEwan EG, Young KM (2001) Canine lymphoma and lymphoid leukemia. Small Anim Clin Oncology. 558-579.

31. Flint C, Gust S, Kutzler MA (2019) Luteinizing hormone receptor-mediated proliferation of isolated canine T-lymphoma cells. Clin Theriogenology. (in press).

32. Navarro, C and Schober, P.A. Pharmacodynamics and pharmacokinetics of a sustained-release implant of deslorelin in companion animals ISCFR Whistler 2012

33. Junaidi, A. et al. Pituitary and testicular endocrine responses to exogenous gonadotrophin-releasing hormone (GnRH) and luteinising hormone in male dogs treated with GnRH agonist implants. Reproduction, Fertility and Development. 2007; 19:891-898

34. Smith J. Canine prostatic disease: A review of anatomy, pathology, diagnosis and treatment. Theriogenology 70 (2008) 375-383

35. Verstegen J. Management of Prostatic Disorders. 27th WSAVA Congress Proceedings, Grenada, Spain (2002)

36. Kutzler MA, Yeager A. Prostatic diseases. In: Ettinger SJ, Feldman EC eds. Textbook of Veterinary Internal Medicine. 6th ed. Elsevier Saunders; 2005, 1809-1819

37. Lopate C. Disease and disorders of the prostate gland in: England and von Heimendahl eds. BSAVA Manual of canine and feline reproduction and neonatology, 2nd Ed, BSAVA; 2010, 202-206

38. Jurczak A, Domoslawska A. et al. Treatment of benign prostatic hyperplasia in dogs using GnRH agonist implant Suprelorin – preliminary results. 7th EVSSAR Congress Proceedings, La Neuve, Belgium (2010)

39. Ponglowhapan S, Lohachit C. Clinical use of GnRH agonist deslorelin in benign prostatic hyperplasia in dogs. 7th EVSSAR Congress Proceedings, La Neuve, Belgium (2010)